Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Nov 4 2016

Full Issue

Cigna Reports Profits Fell After Scrutiny Of Medicare Advantage Plans

Federal officials halted enrollment into the company's Medicare Advantage plans in January because they alleged there were systemic problems that were keeping seniors from getting services and drugs. The company's CEO also says he expects that plans on the health law's marketplace next year will show a loss.

The Wall Street Journal: Cigna’s Profit Falls On Government Business

Cigna Corp. said profit fell in its latest quarter as its government business dragged on results. The government segment’s issues included medical costs in Cigna’s small Medicaid business, particularly in Texas and Illinois. Cigna also faced expenses related to a Centers for Medicare and Medicaid Services audit of its Medicare plans. (Hufford, 11/3)

Hartford Courant: Medicare Advantage Audit Costly For Cigna

Cigna Corp. third quarter profits were down compared to a year ago as costs to reform its Medicare Advantage and Medicare drug prescription programs were a drag on results. ... Cigna has been under sanctions from federal regulators since late January. The Centers for Medicare and Medicaid Services said Cigna had widespread and systemic failures that prevented seniors from accessing medical services and prescription drugs. It said that the ways Cigna operated in restricting access to drugs and services created "a serious threat to enrollees' health and safety." (Lee, 11/3)

Morning Consult: Cigna CEO: Insurer Planning for Obamacare Loss in 2017

The health insurer Cigna is planning for a loss on the Obamacare market next year, its CEO said Thursday. “We are going to expect to see some revenue growth but we are continuing to plan for a loss,” CEO David Cordani said on the company’s third quarter earnings call. The insurer’s strategy to slowly expand into the new marketplace created by the Affordable Care Act has “proven to be more right than wrong,” he said, noting that was unfortunate. (McIntire, 11/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF